CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-21.25%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$470M
AUM Growth
+$470M
(-13%)
Cap. Flow
+$67.5M
Cap. Flow
% of AUM
14.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
3
Reduced
1
Closed
–
Top Buys
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$24.2M |
| 2 |
RAPT Therapeutics
RAPT
|
$23.3M |
| 3 |
Revolution Medicines
RVMD
|
$20.4M |
Top Sells
| 1 |
Surrozen
SRZN
|
$500K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $233M | 49.49% |
18,136,735
+1,890,918
| +12% | +$24.2M |
|
|
2
Revolution Medicines
RVMD
$7.1B
| $85.7M | 18.23% |
4,395,050
+1,047,805
| +31% | +$20.4M |
|
3
Tenaya Therapeutics
TNYA
$184M
| $52.9M | 11.26% |
9,400,290
| – | – |
|
|
4
RAPT Therapeutics
RAPT
$188M
| $48.9M | 10.41% |
2,680,458
+1,278,450
| +91% | +$23.3M |
|
|
5
Surrozen
SRZN
$104M
| $27.7M | 5.9% |
9,248,129
-166,666
| -2% | -$500K |
|
6
Oric Pharmaceuticals
ORIC
$994M
| $16M | 3.4% |
3,568,181
| – | – |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $6.12M | 1.3% |
4,309,329
| – | – |
|